Article: Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.
Vascular health and risk management
2008 Volume 4, Issue 3, Page(s) 575–596
Abstract: Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One ... ...
Abstract | Diabetes mellitus is characterized by a lack of insulin causing elevated blood glucose, often with associated insulin resistance. Over time, especially in genetically susceptible individuals, such chronic hyperglycemia can cause tissue injury. One pathological response to tissue injury is the development of fibrosis, which involves predominant extracellular matrix (ECM) accumulation. The main factors that regulate ECM in diabetes are thought to be pro-sclerotic cytokines and protease/anti-protease systems. This review will examine the key markers and regulators of tissue fibrosis in diabetes and whether their levels in biological fluids may have clinical utility. |
---|---|
MeSH term(s) | Animals ; Basement Membrane/pathology ; Biomarkers/blood ; Biomarkers/metabolism ; Biomarkers/urine ; Cardiomyopathies/metabolism ; Cardiomyopathies/pathology ; Connective Tissue Growth Factor ; Diabetes Complications/blood ; Diabetes Complications/metabolism ; Diabetes Complications/pathology ; Diabetes Complications/urine ; Diabetic Angiopathies/metabolism ; Diabetic Angiopathies/pathology ; Diabetic Nephropathies/metabolism ; Diabetic Nephropathies/pathology ; Diabetic Retinopathy/metabolism ; Diabetic Retinopathy/pathology ; Endothelium, Vascular/pathology ; Extracellular Matrix/metabolism ; Extracellular Matrix/pathology ; Fatty Liver/pathology ; Fibrosis ; Glycation End Products, Advanced/metabolism ; Heart Diseases/metabolism ; Heart Diseases/pathology ; Heart Failure/metabolism ; Heart Failure/pathology ; Humans ; Hyperglycemia/metabolism ; Hyperglycemia/pathology ; Immediate-Early Proteins/metabolism ; Insulin Resistance ; Intercellular Signaling Peptides and Proteins/metabolism ; Liver Cirrhosis/metabolism ; Metalloproteases/metabolism ; Peptide Fragments/blood ; Procollagen/blood ; Renin-Angiotensin System/physiology ; Transforming Growth Factor beta/metabolism ; Tunica Intima/pathology ; Up-Regulation/physiology |
Chemical Substances | Biomarkers ; CCN2 protein, human ; Glycation End Products, Advanced ; Immediate-Early Proteins ; Intercellular Signaling Peptides and Proteins ; Peptide Fragments ; Procollagen ; Transforming Growth Factor beta ; procollagen Type III-N-terminal peptide ; Connective Tissue Growth Factor (139568-91-5) ; Metalloproteases (EC 3.4.-) |
Language | English |
Publishing date | 2008-10-21 |
Publishing country | New Zealand |
Document type | Journal Article ; Review |
ZDB-ID | 2186568-1 |
ISSN | 1178-2048 ; 1176-6344 |
ISSN (online) | 1178-2048 |
ISSN | 1176-6344 |
DOI | 10.2147/vhrm.s1991 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6066: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.